4//SEC Filing
Bell Steven 4
Accession 0001209191-10-041913
CIK 0001420070other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:31 PM ET
Size
7.4 KB
Accession
0001209191-10-041913
Insider Transaction Report
Form 4
Bell Steven
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2010-08-09+100,000→ 100,000 totalExercise: $0.00Exp: 2020-08-09→ Common Stock (100,000 underlying) - Award
Common Stock
2010-08-09+40,000→ 215,705 total
Footnotes (2)
- [F1]This amount represents the par value per underlying share of common stock. The exercise price per share equals the fair market value of a share of common stock as of the grant date, August 9, 2010, which will be determined by an independent valuation to be completed following the grant date.
- [F2]One-third of the option becomes vested and exercisable on August 9, 2011, and 8.33% of the option vests and becomes exercisable every 90 days thereafter until the option becomes fully vested and exercisable.
Documents
Issuer
RESEARCH PHARMACEUTICAL SERVICES, INC.
CIK 0001420070
Entity typeother
Related Parties
1- filerCIK 0001426847
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:31 PM ET
- Size
- 7.4 KB